4//SEC Filing
SPICKSCHEN THORLEF 4
Accession 0000899243-19-000302
CIK 0001466301other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:45 PM ET
Size
10.5 KB
Accession
0000899243-19-000302
Insider Transaction Report
Form 4
SPICKSCHEN THORLEF
Director
Transactions
- Exercise/Conversion
Common Stock
2019-01-03$3.08/sh+6,896$21,240→ 14,514 total - Exercise/Conversion
Common Stock
2019-01-03$0.29/sh+25,862$7,500→ 40,376 total - Exercise/Conversion
Stock Option (right to buy)
2019-01-03−25,862→ 0 totalExercise: $0.29Exp: 2019-08-26→ Common Stock (25,862 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-01-03−6,896→ 0 totalExercise: $3.08Exp: 2020-12-02→ Common Stock (6,896 underlying)
Footnotes (1)
- [F1]The option was exercisable as of the reporting person's previous filing on Form 3, dated as of November 15, 2011.
Documents
Issuer
Clovis Oncology, Inc.
CIK 0001466301
Entity typeother
Related Parties
1- filerCIK 0001268374
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:45 PM ET
- Size
- 10.5 KB